Journal article
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
Cancer cell, Vol.33(4), pp.706-720.e9
04/09/2018
DOI: 10.1016/j.ccell.2018.03.006
PMCID: PMC6143179
PMID: 29622465
Abstract
We characterized the epigenetic landscape of genes encoding long noncoding RNAs (lncRNAs) across 6,475 tumors and 455 cancer cell lines. In stark contrast to the CpG island hypermethylation phenotype in cancer, we observed a recurrent hypomethylation of 1,006 lncRNA genes in cancer, including EPIC1 (epigenetically-induced lncRNA1). Overexpression of EPIC1 is associated with poor prognosis in luminal B breast cancer patients and enhances tumor growth in vitro and in vivo. Mechanistically, EPIC1 promotes cell-cycle progression by interacting with MYC through EPIC1's 129-283 nt region. EPIC1 knockdown reduces the occupancy of MYC to its target genes (e.g., CDKN1A, CCNA2, CDC20, and CDC45). MYC depletion abolishes EPIC1's regulation of MYC target and luminal breast cancer tumorigenesis in vitro and in vivo.
Details
- Title: Subtitle
- lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
- Creators
- Zehua Wang - University of PittsburghBo Yang - University of PittsburghMin Zhang - University of PittsburghWeiwei Guo - University of PittsburghZhiyuan Wu - University of PittsburghYue Wang - University of PittsburghLin Jia - University of PittsburghSong Li - University of PittsburghWen Xie - University of PittsburghDa Yang - University of Pittsburgh
- Contributors
- Cancer Genome Atlas Research NetworkDeqin Ma - University of Iowa, PathologyMohammed M Milhem - University of Iowa, Internal MedicineAaron D Bossler - University of Iowa, Pathology
- Resource Type
- Journal article
- Publication Details
- Cancer cell, Vol.33(4), pp.706-720.e9
- DOI
- 10.1016/j.ccell.2018.03.006
- PMID
- 29622465
- PMCID
- PMC6143179
- ISSN
- 1535-6108
- eISSN
- 1878-3686
- Grant note
- P50 CA159981 / NCI NIH HHS U24 CA210950 / NCI NIH HHS U24 CA210990 / NCI NIH HHS U24 CA210949 / NCI NIH HHS P30 CA047904 / NCI NIH HHS U24 CA210957 / NCI NIH HHS R01 CA163722 / NCI NIH HHS
- Language
- English
- Date published
- 04/09/2018
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pathology; Internal Medicine
- Record Identifier
- 9984185168802771
Metrics
16 Record Views